In vitro activity of BMY-28142, a new cephalosporin.

Abstract:

:BMY-28142 was compared in vitro with ceftazidime, cefotaxime and cefoperazone and was found to be more active against Pseudomonas aeruginosa and Staphylococcus aureus. Essentially no effect of increasing inoculum size 100-fold was seen-on MICs with BMY-28142 or ceftazidime; some effect was noted with cefotaxime and cefoperazone.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Norden CW,Neiderriter K

doi

10.1159/000238470

subject

Has Abstract

pub_date

1987-01-01 00:00:00

pages

15-7

issue

1

eissn

0009-3157

issn

1421-9794

journal_volume

33

pub_type

杂志文章